ADHD
Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
CompletedNCT06000501
Official study titleAn Open-Label Treatment, Investigator-Initiated Study, on the Duration and Efficacy of Azstarys (Serdexmethylphenidate and Dexmethylphenidate) on Adult ADHD Symptoms and Executive Function in Early Evening
This study has finished and is no longer accepting participants.
In New YorkADHDMedication studyAges 18–60
- Countries
- United States
- Sponsor
- NYU Langone Health
CompletedNCT03088267
Official study titleDyanavel® XR Extended-Release Oral Suspension in the Treatment of Children Wit
This study has finished and is no longer accepting participants.
In Las VegasADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Tris Pharma, Inc.
CompletedNCT02271386
This study has finished and is no longer accepting participants.
In PhiladelphiaADHDBehavioural studyAges 5–12
- Countries
- United States
- Sponsor
- Children's Hospital of Philadelphia
CompletedNCT01055119
Official study titleEffect of Supplementation With Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including UlmADHDPlacebo comparisonAges 6–12
- Countries
- Germany
- Sponsor
- University of Ulm
CompletedNCT05522478
Official study titleEffect Of Methylphenidate On Static Balance And Fall Risk In Children With Attention Deficit Hyperactivity Disorder: Cross-Sectional Study
This study has finished and is no longer accepting participants.
In IstanbulADHDObservational studyAges 8–12
- Countries
- Türkiye
- Sponsor
- Fatih Sultan Mehmet Training and Research Hospital
WithdrawnNCT01764672
Official study titleEffects of Methylphenidate on Resting State Connectivity in Healthy Controls and in Adults With Attention Deficit Hyperactivity Disorder.
This study was withdrawn before enrollment.
In UtrechtADHDMedication studyAges 18–40
- Countries
- Netherlands
- Sponsor
- Iris Sommer
CompletedNCT00801229
Official study titleThe Effects of Vyvanse on the Driving Performance of Young Adults With ADHD: A Randomized, Double-Blind, Placebo-Controlled Study
This study has finished and is no longer accepting participants.
In CambridgeADHDMedication studyAges 18–24
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT02151396
This study has finished and is no longer accepting participants.
In HartfordADHDDevice studyAges 13–17
- Countries
- United States
- Sponsor
- Hartford Hospital
TerminatedNCT03481959
This study ended early.
In ParisADHDMedication studyAges 12–25
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
CompletedNCT06006871
Official study titleThe Secret Trail of Moon (MOON): a Personalized Treatment Video Game for Children and Adolescents With ADHD Based on Cognitive Training and Self-regulation
This study has finished and is no longer accepting participants.
In MajadahondaADHDMedication studyAges 7–18
- Countries
- Spain
- Sponsor
- Puerta de Hierro University Hospital
CompletedNCT02518711
Official study titleA Randomized Controlled Trial Into the Effectiveness of a Behavioral Teacher Program Targeting ADHD Symptoms
This study has finished and is no longer accepting participants.
Location not clearly listedADHDBehavioural studyAges 6–13
- Countries
- Sponsor
- VU University of Amsterdam
CompletedNCT03533556
Official study titleEffects of L-theanine and Caffeine on Attention and Attention-related Brain Activity of Male Children and Adolescents With Attention Deficit Hyperactivity Disorder: a proof-of- Concept fMRI Study.
This study has finished and is no longer accepting participants.
In LubbockADHDPlacebo researchAges 8–17
- Countries
- United States
- Sponsor
- Texas Tech University